Pancreatic Beta-Cell Protection Market - Global Outlook and Forecast 2021-2027

Code: RW00014534782
Market Monitor Global
Oct-2021
Life Sciences
108 Pages

This report contains market size and forecasts of Pancreatic Beta-Cell Protection in Global, including the following market information:
Global Pancreatic Beta-Cell Protection Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Pancreatic Beta-Cell Protection market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pancreatic Beta-Cell Protection companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pancreatic Beta-Cell Protection Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Pancreatic Beta-Cell Protection Market Segment Percentages, By Type, 2020 (%)
Stem Cell Based
Gene Therapies
RNA Based Therapies
Monoclonal Antibodies (MAbs)
Phytotherapy

China Pancreatic Beta-Cell Protection Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Pancreatic Beta-Cell Protection Market Segment Percentages, By Application, 2020 (%)
Hospital
Medical Research Laboratory
Others

Global Pancreatic Beta-Cell Protection Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Pancreatic Beta-Cell Protection Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Pancreatic Beta-Cell Protection Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Pancreatic Beta-Cell Protection Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
ViaCyte
PharmaCyte Biotech
Boehringer Ingelheim
GalaxoSmithKline
Beta-Cell NV
Novartis
Janssen Research & Development
Pfizer Inc
BioLineRx
Genentech
Novo Nordisk
Sanofi
Osiris Therapeutics
Beta-O2 Technologies Ltd
Transition Therapeutics

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Pancreatic Beta-Cell Protection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pancreatic Beta-Cell Protection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pancreatic Beta-Cell Protection Overall Market Size
2.1 Global Pancreatic Beta-Cell Protection Market Size: 2021 VS 2027
2.2 Global Pancreatic Beta-Cell Protection Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pancreatic Beta-Cell Protection Players in Global Market
3.2 Top Global Pancreatic Beta-Cell Protection Companies Ranked by Revenue
3.3 Global Pancreatic Beta-Cell Protection Revenue by Companies
3.4 Top 3 and Top 5 Pancreatic Beta-Cell Protection Companies in Global Market, by Revenue in 2020
3.5 Global Companies Pancreatic Beta-Cell Protection Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pancreatic Beta-Cell Protection Players in Global Market
3.6.1 List of Global Tier 1 Pancreatic Beta-Cell Protection Companies
3.6.2 List of Global Tier 2 and Tier 3 Pancreatic Beta-Cell Protection Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pancreatic Beta-Cell Protection Market Size Markets, 2021 & 2027
4.1.2 Stem Cell Based
4.1.3 Gene Therapies
4.1.4 RNA Based Therapies
4.1.5 Monoclonal Antibodies (MAbs)
4.1.6 Phytotherapy
4.2 By Type - Global Pancreatic Beta-Cell Protection Revenue & Forecasts
4.2.1 By Type - Global Pancreatic Beta-Cell Protection Revenue, 2016-2021
4.2.2 By Type - Global Pancreatic Beta-Cell Protection Revenue, 2022-2027
4.2.3 By Type - Global Pancreatic Beta-Cell Protection Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pancreatic Beta-Cell Protection Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Medical Research Laboratory
5.1.4 Others
5.2 By Application - Global Pancreatic Beta-Cell Protection Revenue & Forecasts
5.2.1 By Application - Global Pancreatic Beta-Cell Protection Revenue, 2016-2021
5.2.2 By Application - Global Pancreatic Beta-Cell Protection Revenue, 2022-2027
5.2.3 By Application - Global Pancreatic Beta-Cell Protection Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Pancreatic Beta-Cell Protection Market Size, 2021 & 2027
6.2 By Region - Global Pancreatic Beta-Cell Protection Revenue & Forecasts
6.2.1 By Region - Global Pancreatic Beta-Cell Protection Revenue, 2016-2021
6.2.2 By Region - Global Pancreatic Beta-Cell Protection Revenue, 2022-2027
6.2.3 By Region - Global Pancreatic Beta-Cell Protection Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Pancreatic Beta-Cell Protection Revenue, 2016-2027
6.3.2 US Pancreatic Beta-Cell Protection Market Size, 2016-2027
6.3.3 Canada Pancreatic Beta-Cell Protection Market Size, 2016-2027
6.3.4 Mexico Pancreatic Beta-Cell Protection Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Pancreatic Beta-Cell Protection Revenue, 2016-2027
6.4.2 Germany Pancreatic Beta-Cell Protection Market Size, 2016-2027
6.4.3 France Pancreatic Beta-Cell Protection Market Size, 2016-2027
6.4.4 U.K. Pancreatic Beta-Cell Protection Market Size, 2016-2027
6.4.5 Italy Pancreatic Beta-Cell Protection Market Size, 2016-2027
6.4.6 Russia Pancreatic Beta-Cell Protection Market Size, 2016-2027
6.4.7 Nordic Countries Pancreatic Beta-Cell Protection Market Size, 2016-2027
6.4.8 Benelux Pancreatic Beta-Cell Protection Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Pancreatic Beta-Cell Protection Revenue, 2016-2027
6.5.2 China Pancreatic Beta-Cell Protection Market Size, 2016-2027
6.5.3 Japan Pancreatic Beta-Cell Protection Market Size, 2016-2027
6.5.4 South Korea Pancreatic Beta-Cell Protection Market Size, 2016-2027
6.5.5 Southeast Asia Pancreatic Beta-Cell Protection Market Size, 2016-2027
6.5.6 India Pancreatic Beta-Cell Protection Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Pancreatic Beta-Cell Protection Revenue, 2016-2027
6.6.2 Brazil Pancreatic Beta-Cell Protection Market Size, 2016-2027
6.6.3 Argentina Pancreatic Beta-Cell Protection Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pancreatic Beta-Cell Protection Revenue, 2016-2027
6.7.2 Turkey Pancreatic Beta-Cell Protection Market Size, 2016-2027
6.7.3 Israel Pancreatic Beta-Cell Protection Market Size, 2016-2027
6.7.4 Saudi Arabia Pancreatic Beta-Cell Protection Market Size, 2016-2027
6.7.5 UAE Pancreatic Beta-Cell Protection Market Size, 2016-2027
7 Players Profiles
7.1 ViaCyte
7.1.1 ViaCyte Corporate Summary
7.1.2 ViaCyte Business Overview
7.1.3 ViaCyte Pancreatic Beta-Cell Protection Major Product Offerings
7.1.4 ViaCyte Pancreatic Beta-Cell Protection Revenue in Global (2016-2021)
7.1.5 ViaCyte Key News
7.2 PharmaCyte Biotech
7.2.1 PharmaCyte Biotech Corporate Summary
7.2.2 PharmaCyte Biotech Business Overview
7.2.3 PharmaCyte Biotech Pancreatic Beta-Cell Protection Major Product Offerings
7.2.4 PharmaCyte Biotech Pancreatic Beta-Cell Protection Revenue in Global (2016-2021)
7.2.5 PharmaCyte Biotech Key News
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporate Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Pancreatic Beta-Cell Protection Major Product Offerings
7.3.4 Boehringer Ingelheim Pancreatic Beta-Cell Protection Revenue in Global (2016-2021)
7.3.5 Boehringer Ingelheim Key News
7.4 GalaxoSmithKline
7.4.1 GalaxoSmithKline Corporate Summary
7.4.2 GalaxoSmithKline Business Overview
7.4.3 GalaxoSmithKline Pancreatic Beta-Cell Protection Major Product Offerings
7.4.4 GalaxoSmithKline Pancreatic Beta-Cell Protection Revenue in Global (2016-2021)
7.4.5 GalaxoSmithKline Key News
7.5 Beta-Cell NV
7.5.1 Beta-Cell NV Corporate Summary
7.5.2 Beta-Cell NV Business Overview
7.5.3 Beta-Cell NV Pancreatic Beta-Cell Protection Major Product Offerings
7.5.4 Beta-Cell NV Pancreatic Beta-Cell Protection Revenue in Global (2016-2021)
7.5.5 Beta-Cell NV Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Pancreatic Beta-Cell Protection Major Product Offerings
7.6.4 Novartis Pancreatic Beta-Cell Protection Revenue in Global (2016-2021)
7.6.5 Novartis Key News
7.7 Janssen Research & Development
7.7.1 Janssen Research & Development Corporate Summary
7.7.2 Janssen Research & Development Business Overview
7.7.3 Janssen Research & Development Pancreatic Beta-Cell Protection Major Product Offerings
7.4.4 Janssen Research & Development Pancreatic Beta-Cell Protection Revenue in Global (2016-2021)
7.7.5 Janssen Research & Development Key News
7.8 Pfizer Inc
7.8.1 Pfizer Inc Corporate Summary
7.8.2 Pfizer Inc Business Overview
7.8.3 Pfizer Inc Pancreatic Beta-Cell Protection Major Product Offerings
7.8.4 Pfizer Inc Pancreatic Beta-Cell Protection Revenue in Global (2016-2021)
7.8.5 Pfizer Inc Key News
7.9 BioLineRx
7.9.1 BioLineRx Corporate Summary
7.9.2 BioLineRx Business Overview
7.9.3 BioLineRx Pancreatic Beta-Cell Protection Major Product Offerings
7.9.4 BioLineRx Pancreatic Beta-Cell Protection Revenue in Global (2016-2021)
7.9.5 BioLineRx Key News
7.10 Genentech
7.10.1 Genentech Corporate Summary
7.10.2 Genentech Business Overview
7.10.3 Genentech Pancreatic Beta-Cell Protection Major Product Offerings
7.10.4 Genentech Pancreatic Beta-Cell Protection Revenue in Global (2016-2021)
7.10.5 Genentech Key News
7.11 Novo Nordisk
7.11.1 Novo Nordisk Corporate Summary
7.11.2 Novo Nordisk Business Overview
7.11.3 Novo Nordisk Pancreatic Beta-Cell Protection Major Product Offerings
7.11.4 Novo Nordisk Pancreatic Beta-Cell Protection Revenue in Global (2016-2021)
7.11.5 Novo Nordisk Key News
7.12 Sanofi
7.12.1 Sanofi Corporate Summary
7.12.2 Sanofi Business Overview
7.12.3 Sanofi Pancreatic Beta-Cell Protection Major Product Offerings
7.12.4 Sanofi Pancreatic Beta-Cell Protection Revenue in Global (2016-2021)
7.12.5 Sanofi Key News
7.13 Osiris Therapeutics
7.13.1 Osiris Therapeutics Corporate Summary
7.13.2 Osiris Therapeutics Business Overview
7.13.3 Osiris Therapeutics Pancreatic Beta-Cell Protection Major Product Offerings
7.13.4 Osiris Therapeutics Pancreatic Beta-Cell Protection Revenue in Global (2016-2021)
7.13.5 Osiris Therapeutics Key News
7.14 Beta-O2 Technologies Ltd
7.14.1 Beta-O2 Technologies Ltd Corporate Summary
7.14.2 Beta-O2 Technologies Ltd Business Overview
7.14.3 Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Major Product Offerings
7.14.4 Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Revenue in Global (2016-2021)
7.14.5 Beta-O2 Technologies Ltd Key News
7.15 Transition Therapeutics
7.15.1 Transition Therapeutics Corporate Summary
7.15.2 Transition Therapeutics Business Overview
7.15.3 Transition Therapeutics Pancreatic Beta-Cell Protection Major Product Offerings
7.15.4 Transition Therapeutics Pancreatic Beta-Cell Protection Revenue in Global (2016-2021)
7.15.5 Transition Therapeutics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Pancreatic Beta-Cell Protection Market Opportunities & Trends in Global Market
Table 2. Pancreatic Beta-Cell Protection Market Drivers in Global Market
Table 3. Pancreatic Beta-Cell Protection Market Restraints in Global Market
Table 4. Key Players of Pancreatic Beta-Cell Protection in Global Market
Table 5. Top Pancreatic Beta-Cell Protection Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Pancreatic Beta-Cell Protection Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Pancreatic Beta-Cell Protection Revenue Share by Companies, 2016-2021
Table 8. Global Companies Pancreatic Beta-Cell Protection Product Type
Table 9. List of Global Tier 1 Pancreatic Beta-Cell Protection Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pancreatic Beta-Cell Protection Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

ViaCyte
PharmaCyte Biotech
Boehringer Ingelheim
GalaxoSmithKline
Beta-Cell NV
Novartis
Janssen Research & Development
Pfizer Inc
BioLineRx
Genentech
Novo Nordisk
Sanofi
Osiris Therapeutics
Beta-O2 Technologies Ltd
Transition Therapeutics

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE